HDL particles – more complex than we thought

Insight on: Holy et al. Thromb Haemost 2014; 112: 1024-1035.

• References

• 1 Di Angelantonio E. et al. Major lipids, apolipoproteins, and risk of vascular disease. J Am Med Assoc 2009; 302: 1993-2000.
• 2 Badimon L, Vilahur G. LDL-cholesterol versus HDL-cholesterol in the atherosclerotic plaque: inflammatory resolution versus thrombotic chaos. Ann NY Acad Sci 2012; 1254: 18-32.
• 3 Besler C, Heinrich K, Rohrer L. et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 2011; 121: 2693-2708.
• 4 Holy EW, Besler C, Reiner MF. et al. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation. Thromb Haemost 2014; 112: 1024-1035.